Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Influenza virus with increased pH of HA activation has improved replication in cell culture but at the cost of infectivity in human airway epithelium.

Singanayagam A, Zambon M, Barclay W.

J Virol. 2019 Jun 12. pii: JVI.00058-19. doi: 10.1128/JVI.00058-19. [Epub ahead of print]

2.

Serological surveillance of influenza in an English sentinel network: pilot study protocol.

de Lusignan S, Borrow R, Tripathy M, Linley E, Zambon M, Hoschler K, Ferreira F, Andrews N, Yonova I, Hriskova M, Rafi I, Pebody R.

BMJ Open. 2019 Mar 8;9(3):e024285. doi: 10.1136/bmjopen-2018-024285.

3.

Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion.

Walls AC, Xiong X, Park YJ, Tortorici MA, Snijder J, Quispe J, Cameroni E, Gopal R, Dai M, Lanzavecchia A, Zambon M, Rey FA, Corti D, Veesler D.

Cell. 2019 Feb 21;176(5):1026-1039.e15. doi: 10.1016/j.cell.2018.12.028. Epub 2019 Jan 31.

PMID:
30712865
4.

Prophylactic efficacy of a human monoclonal antibody against MERS-CoV in the common marmoset.

de Wit E, Feldmann F, Horne E, Okumura A, Cameroni E, Haddock E, Saturday G, Scott D, Gopal R, Zambon M, Corti D, Feldmann H.

Antiviral Res. 2019 Mar;163:70-74. doi: 10.1016/j.antiviral.2019.01.016. Epub 2019 Jan 24.

PMID:
30684561
5.

Polio eradication: next steps and future challenges.

Zambon M, Martin J.

Euro Surveill. 2018 Nov;23(47). doi: 10.2807/1560-7917.ES.2018.23.47.1800625. No abstract available.

6.

Determining the Mutation Bias of Favipiravir in Influenza Virus Using Next-Generation Sequencing.

Goldhill DH, Langat P, Xie H, Galiano M, Miah S, Kellam P, Zambon M, Lackenby A, Barclay WS.

J Virol. 2019 Jan 4;93(2). pii: e01217-18. doi: 10.1128/JVI.01217-18. Print 2019 Jan 15.

7.

The mechanism of resistance to favipiravir in influenza.

Goldhill DH, Te Velthuis AJW, Fletcher RA, Langat P, Zambon M, Lackenby A, Barclay WS.

Proc Natl Acad Sci U S A. 2018 Nov 6;115(45):11613-11618. doi: 10.1073/pnas.1811345115. Epub 2018 Oct 23.

8.

Uptake and effectiveness of influenza vaccine in those aged 65 years and older in the United Kingdom, influenza seasons 2010/11 to 2016/17.

Pebody RG, Warburton F, Andrews N, Sinnathamby M, Yonova I, Reynolds A, Robertson C, Cottrell S, Sartaj M, Gunson R, Donati M, Moore C, Ellis J, de Lusignan S, McMenamin J, Zambon M.

Euro Surveill. 2018 Sep;23(39). doi: 10.2807/1560-7917.ES.2018.23.39.1800092.

9.

Flu vaccines: an annual challenge.

Pebody RG, Zambon M, Ramsay M.

BMJ. 2018 Jun 27;361:k2705. doi: 10.1136/bmj.k2705. No abstract available.

PMID:
29950432
10.

Uptake and impact of vaccinating primary school-age children against influenza: experiences of a live attenuated influenza vaccine programme, England, 2015/16.

Pebody RG, Sinnathamby MA, Warburton F, Andrews N, Boddington NL, Zhao H, Yonova I, Ellis J, Tessier E, Donati M, Elliot AJ, Hughes HE, Pathirannehelage S, Byford R, Smith GE, de Lusignan S, Zambon M.

Euro Surveill. 2018 Jun;23(25). doi: 10.2807/1560-7917.ES.2018.23.25.1700496.

11.

Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014.

Caini S, Spreeuwenberg P, Kusznierz GF, Rudi JM, Owen R, Pennington K, Wangchuk S, Gyeltshen S, Ferreira de Almeida WA, Pessanha Henriques CM, Njouom R, Vernet MA, Fasce RA, Andrade W, Yu H, Feng L, Yang J, Peng Z, Lara J, Bruno A, de Mora D, de Lozano C, Zambon M, Pebody R, Castillo L, Clara AW, Matute ML, Kosasih H, Nurhayati, Puzelli S, Rizzo C, Kadjo HA, Daouda C, Kiyanbekova L, Ospanova A, Mott JA, Emukule GO, Heraud JM, Razanajatovo NH, Barakat A, El Falaki F, Huang SQ, Lopez L, Balmaseda A, Moreno B, Rodrigues AP, Guiomar R, Ang LW, Lee VJM, Venter M, Cohen C, Badur S, Ciblak MA, Mironenko A, Holubka O, Bresee J, Brammer L, Hoang PVM, Le MTQ, Fleming D, Séblain CE, Schellevis F, Paget J; Global Influenza B Study group.

BMC Infect Dis. 2018 Jun 8;18(1):269. doi: 10.1186/s12879-018-3181-y.

12.

Responses to live attenuated influenza vaccine in children vaccinated previously with Pandemrix (ASO3B adjuvanted pandemic A/H1N1pdm09).

Höschler K, Southern J, Thompson C, Warburton F, Andrews NJ, Miller E, Zambon M.

Vaccine. 2018 May 17;36(21):3034-3040. doi: 10.1016/j.vaccine.2018.04.017. Epub 2018 Apr 19.

PMID:
29680198
13.

Can defective interfering RNAs affect the live attenuated influenza vaccine? - Authors' reply.

Singanayagam A, Zambon M, Lalvani A, Barclay W.

Lancet Infect Dis. 2017 Dec;17(12):1235-1236. doi: 10.1016/S1473-3099(17)30638-2. No abstract available.

14.

End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17.

Pebody R, Warburton F, Ellis J, Andrews N, Potts A, Cottrell S, Reynolds A, Gunson R, Thompson C, Galiano M, Robertson C, Gallagher N, Sinnathamby M, Yonova I, Correa A, Moore C, Sartaj M, de Lusignan S, McMenamin J, Zambon M.

Euro Surveill. 2017 Nov;22(44). doi: 10.2807/1560-7917.ES.2017.22.44.17-00306.

15.

Effects of seasonal and pandemic influenza on health-related quality of life, work and school absence in England: Results from the Flu Watch cohort study.

Fragaszy EB, Warren-Gash C, White PJ, Zambon M, Edmunds WJ, Nguyen-Van-Tam JS, Hayward AC; Flu Watch Group.

Influenza Other Respir Viruses. 2018 Jan;12(1):171-182. doi: 10.1111/irv.12506.

16.

Urgent challenges in implementing live attenuated influenza vaccine.

Singanayagam A, Zambon M, Lalvani A, Barclay W.

Lancet Infect Dis. 2018 Jan;18(1):e25-e32. doi: 10.1016/S1473-3099(17)30360-2. Epub 2017 Aug 2. Review.

17.

The UK's multidisciplinary response to an Ebola epidemic.

Reece S, Brown CS, Dunning J, Chand MA, Zambon MC, Jacobs M.

Clin Med (Lond). 2017 Jul;17(4):332-337. doi: 10.7861/clinmedicine.17-4-332.

18.

Antibody-based assay discriminates Zika virus infection from other flaviviruses.

Balmaseda A, Stettler K, Medialdea-Carrera R, Collado D, Jin X, Zambrana JV, Jaconi S, Cameroni E, Saborio S, Rovida F, Percivalle E, Ijaz S, Dicks S, Ushiro-Lumb I, Barzon L, Siqueira P, Brown DWG, Baldanti F, Tedder R, Zambon M, de Filippis AMB, Harris E, Corti D.

Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8384-8389. doi: 10.1073/pnas.1704984114. Epub 2017 Jul 17.

19.

Global outbreak of severe Mycobacterium chimaera disease after cardiac surgery: a molecular epidemiological study.

van Ingen J, Kohl TA, Kranzer K, Hasse B, Keller PM, Katarzyna Szafrańska A, Hillemann D, Chand M, Schreiber PW, Sommerstein R, Berger C, Genoni M, Rüegg C, Troillet N, Widmer AF, Becker SL, Herrmann M, Eckmanns T, Haller S, Höller C, Debast SB, Wolfhagen MJ, Hopman J, Kluytmans J, Langelaar M, Notermans DW, Ten Oever J, van den Barselaar P, Vonk ABA, Vos MC, Ahmed N, Brown T, Crook D, Lamagni T, Phin N, Smith EG, Zambon M, Serr A, Götting T, Ebner W, Thürmer A, Utpatel C, Spröer C, Bunk B, Nübel U, Bloemberg GV, Böttger EC, Niemann S, Wagner D, Sax H.

Lancet Infect Dis. 2017 Oct;17(10):1033-1041. doi: 10.1016/S1473-3099(17)30324-9. Epub 2017 Jul 12.

PMID:
28711585
20.

Influenza vaccine: going through a sticky patch.

Höschler K, Zambon MC.

Lancet. 2017 Aug 12;390(10095):627-628. doi: 10.1016/S0140-6736(17)31364-8. Epub 2017 Jun 27. No abstract available.

PMID:
28666679
21.

Comparison of mucosal lining fluid sampling methods and influenza-specific IgA detection assays for use in human studies of influenza immunity.

de Silva TI, Gould V, Mohammed NI, Cope A, Meijer A, Zutt I, Reimerink J, Kampmann B, Hoschler K, Zambon M, Tregoning JS.

J Immunol Methods. 2017 Oct;449:1-6. doi: 10.1016/j.jim.2017.06.008. Epub 2017 Jun 21.

22.

Evidence synthesis and decision modelling to support complex decisions: stockpiling neuraminidase inhibitors for pandemic influenza usage.

Watson SI, Chen YF, Nguyen-Van-Tam JS, Myles PR, Venkatesan S, Zambon M, Uthman O, Chilton PJ, Lilford RJ.

Version 2. F1000Res. 2016 Sep 12 [revised 2017 Jan 1];5:2293. doi: 10.12688/f1000research.9414.2. eCollection 2016.

23.

M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza.

Cole SL, Dunning J, Kok WL, Benam KH, Benlahrech A, Repapi E, Martinez FO, Drumright L, Powell TJ, Bennett M, Elderfield R, Thomas C; MOSAIC investigators, Dong T, McCauley J, Liew FY, Taylor S, Zambon M, Barclay W, Cerundolo V, Openshaw PJ, McMichael AJ, Ho LP.

JCI Insight. 2017 Apr 6;2(7):e91868. doi: 10.1172/jci.insight.91868.

24.

Insidious Risk of Severe Mycobacterium chimaera Infection in Cardiac Surgery Patients.

Chand M, Lamagni T, Kranzer K, Hedge J, Moore G, Parks S, Collins S, Del Ojo Elias C, Ahmed N, Brown T, Smith EG, Hoffman P, Kirwan P, Mason B, Smith-Palmer A, Veal P, Lalor MK, Bennett A, Walker J, Yeap A, Isidro Carrion Martin A, Dolan G, Bhatt S, Skingsley A, Charlett A, Pearce D, Russell K, Kendall S, Klein AA, Robins S, Schelenz S, Newsholme W, Thomas S, Collyns T, Davies E, McMenamin J, Doherty L, Peto TE, Crook D, Zambon M, Phin N.

Clin Infect Dis. 2017 Feb 1;64(3):335-342. doi: 10.1093/cid/ciw754. Epub 2016 Dec 7. Erratum in: Clin Infect Dis. 2017 Sep 1;65(5):875.

25.

Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results.

Pebody R, Warburton F, Ellis J, Andrews N, Potts A, Cottrell S, Johnston J, Reynolds A, Gunson R, Thompson C, Galiano M, Robertson C, Byford R, Gallagher N, Sinnathamby M, Yonova I, Pathirannehelage S, Donati M, Moore C, de Lusignan S, McMenamin J, Zambon M.

Euro Surveill. 2016 Sep 22;21(38). doi: 10.2807/1560-7917.ES.2016.21.38.30348.

26.

Zika virus, the new kid on the block.

Zambon M.

Euro Surveill. 2016 Jun 9;21(23). doi: 10.2807/1560-7917.ES.2016.21.23.30255. No abstract available.

27.

Late Ebola virus relapse causing meningoencephalitis: a case report.

Jacobs M, Rodger A, Bell DJ, Bhagani S, Cropley I, Filipe A, Gifford RJ, Hopkins S, Hughes J, Jabeen F, Johannessen I, Karageorgopoulos D, Lackenby A, Lester R, Liu RS, MacConnachie A, Mahungu T, Martin D, Marshall N, Mepham S, Orton R, Palmarini M, Patel M, Perry C, Peters SE, Porter D, Ritchie D, Ritchie ND, Seaton RA, Sreenu VB, Templeton K, Warren S, Wilkie GS, Zambon M, Gopal R, Thomson EC.

Lancet. 2016 Jul 30;388(10043):498-503. doi: 10.1016/S0140-6736(16)30386-5. Epub 2016 May 18.

28.

Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndrome.

Corti D, Passini N, Lanzavecchia A, Zambon M.

J Infect Public Health. 2016 May-Jun;9(3):231-5. doi: 10.1016/j.jiph.2016.04.003. Epub 2016 Apr 19. Review.

29.

Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season results.

Pebody R, Warburton F, Ellis J, Andrews N, Potts A, Cottrell S, Johnston J, Reynolds A, Gunson R, Thompson C, Galiano M, Robertson C, Mullett D, Gallagher N, Sinnathamby M, Yonova I, Moore C, McMenamin J, de Lusignan S, Zambon M.

Euro Surveill. 2016;21(13). doi: 10.2807/1560-7917.ES.2016.21.13.30179.

30.

Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination?

Caini S, Andrade W, Badur S, Balmaseda A, Barakat A, Bella A, Bimohuen A, Brammer L, Bresee J, Bruno A, Castillo L, Ciblak MA, Clara AW, Cohen C, Cutter J, Daouda C, de Lozano C, De Mora D, Dorji K, Emukule GO, Fasce RA, Feng L, Ferreira de Almeida WA, Guiomar R, Heraud JM, Holubka O, Huang QS, Kadjo HA, Kiyanbekova L, Kosasih H, Kusznierz G, Lara J, Li M, Lopez L, Mai Hoang PV, Pessanha Henriques CM, Matute ML, Mironenko A, Moreno B, Mott JA, Njouom R, Nurhayati, Ospanova A, Owen R, Pebody R, Pennington K, Puzelli S, Quynh Le MT, Razanajatovo NH, Rodrigues A, Rudi JM, Tzer Pin Lin R, Venter M, Vernet MA, Wangchuk S, Yang J, Yu H, Zambon M, Schellevis F, Paget J; Global Influenza B Study.

PLoS One. 2016 Mar 31;11(3):e0152310. doi: 10.1371/journal.pone.0152310. eCollection 2016. Erratum in: PLoS One. 2016;11(5):e0155089.

31.

Corrigendum: Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events.

Sobolev O, Binda E, O'Farrell S, Lorenc A, Pradines J, Huang Y, Duffner J, Schulz R, Cason J, Zambon M, Malim MH, Peakman M, Cope A, Capila I, Kaundinya GV, Hayday AC.

Nat Immunol. 2016 Apr;17(4):469. doi: 10.1038/ni0416-469b. No abstract available.

PMID:
27002849
32.

Cohort Profile: The Flu Watch Study.

Fragaszy EB, Warren-Gash C, Wang L, Copas A, Dukes O, Edmunds WJ, Goonetilleke N, Harvey G, Johnson AM, Kovar J, Lim MS, McMichael A, Millett ER, Nazareth I, Nguyen-Van-Tam JS, Tabassum F, Watson JM, Wurie F, Zambon M, Hayward AC; Flu Watch Group.

Int J Epidemiol. 2017 Apr 1;46(2):e18. doi: 10.1093/ije/dyv370. No abstract available.

33.

Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events.

Sobolev O, Binda E, O'Farrell S, Lorenc A, Pradines J, Huang Y, Duffner J, Schulz R, Cason J, Zambon M, Malim MH, Peakman M, Cope A, Capila I, Kaundinya GV, Hayday AC.

Nat Immunol. 2016 Feb;17(2):204-13. doi: 10.1038/ni.3328. Epub 2016 Jan 4. Erratum in: Nat Immunol. 2016 Apr;17(4):469.

34.

Uptake and impact of vaccinating school age children against influenza during a season with circulation of drifted influenza A and B strains, England, 2014/15.

Pebody RG, Green HK, Andrews N, Boddington NL, Zhao H, Yonova I, Ellis J, Steinberger S, Donati M, Elliot AJ, Hughes HE, Pathirannehelage S, Mullett D, Smith GE, de Lusignan S, Zambon M.

Euro Surveill. 2015;20(39). doi: 10.2807/1560-7917.ES.2015.20.39.30029.

35.

Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results.

Pebody R, Warburton F, Andrews N, Ellis J, von Wissmann B, Robertson C, Yonova I, Cottrell S, Gallagher N, Green H, Thompson C, Galiano M, Marques D, Gunson R, Reynolds A, Moore C, Mullett D, Pathirannehelage S, Donati M, Johnston J, de Lusignan S, McMenamin J, Zambon M.

Euro Surveill. 2015;20(36). doi: 10.2807/1560-7917.ES.2015.20.36.30013.

36.

Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study.

Caini S, Huang QS, Ciblak MA, Kusznierz G, Owen R, Wangchuk S, Henriques CM, Njouom R, Fasce RA, Yu H, Feng L, Zambon M, Clara AW, Kosasih H, Puzelli S, Kadjo HA, Emukule G, Heraud JM, Ang LW, Venter M, Mironenko A, Brammer L, Mai le TQ, Schellevis F, Plotkin S, Paget J; Global Influenza B Study.

Influenza Other Respir Viruses. 2015 Aug;9 Suppl 1:3-12. doi: 10.1111/irv.12319.

37.

Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus.

Corti D, Zhao J, Pedotti M, Simonelli L, Agnihothram S, Fett C, Fernandez-Rodriguez B, Foglierini M, Agatic G, Vanzetta F, Gopal R, Langrish CJ, Barrett NA, Sallusto F, Baric RS, Varani L, Zambon M, Perlman S, Lanzavecchia A.

Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10473-8. doi: 10.1073/pnas.1510199112. Epub 2015 Jul 27.

38.

Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study.

Hayward AC, Wang L, Goonetilleke N, Fragaszy EB, Bermingham A, Copas A, Dukes O, Millett ER, Nazareth I, Nguyen-Van-Tam JS, Watson JM, Zambon M; Flu Watch Group, Johnson AM, McMichael AJ.

Am J Respir Crit Care Med. 2015 Jun 15;191(12):1422-31. doi: 10.1164/rccm.201411-1988OC.

39.

Developments in the treatment of severe influenza: lessons from the pandemic of 2009 and new prospects for therapy.

Zambon M.

Curr Opin Infect Dis. 2014 Dec;27(6):560-5. doi: 10.1097/QCO.0000000000000113. Review.

PMID:
25333476
40.

Accumulation of human-adapting mutations during circulation of A(H1N1)pdm09 influenza virus in humans in the United Kingdom.

Elderfield RA, Watson SJ, Godlee A, Adamson WE, Thompson CI, Dunning J, Fernandez-Alonso M, Blumenkrantz D, Hussell T; MOSAIC Investigators, Zambon M, Openshaw P, Kellam P, Barclay WS.

J Virol. 2014 Nov;88(22):13269-83. doi: 10.1128/JVI.01636-14. Epub 2014 Sep 10.

41.

Enhanced MERS coronavirus surveillance of travelers from the Middle East to England.

Thomas HL, Zhao H, Green HK, Boddington NL, Carvalho CF, Osman HK, Sadler C, Zambon M, Bermingham A, Pebody RG.

Emerg Infect Dis. 2014 Sep;20(9):1562-4. doi: 10.3201/eid2009.140817.

42.

Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination.

Pedersen GK, Höschler K, Øie Solbak SM, Bredholt G, Pathirana RD, Afsar A, Breakwell L, Nøstbakken JK, Raae AJ, Brokstad KA, Sjursen H, Zambon M, Cox RJ.

Vaccine. 2014 Jul 31;32(35):4550-7. doi: 10.1016/j.vaccine.2014.06.009. Epub 2014 Jun 18.

PMID:
24950357
43.

An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans.

Krammer F, Jul-Larsen A, Margine I, Hirsh A, Sjursen H, Zambon M, Cox RJ.

Clin Vaccine Immunol. 2014 Aug;21(8):1153-63. doi: 10.1128/CVI.00272-14. Epub 2014 Jun 18.

44.

Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year-olds.

Nicholson KG, Abrams KR, Batham S, Medina MJ, Warren FC, Barer M, Bermingham A, Clark TW, Latimer N, Fraser M, Perera N, Rajakumar K, Zambon M.

Health Technol Assess. 2014 May;18(36):1-274, vii-viii. doi: 10.3310/hta18360.

45.

London 2012 Olympic and Paralympic Games: public health surveillance and epidemiology.

McCloskey B, Endericks T, Catchpole M, Zambon M, McLauchlin J, Shetty N, Manuel R, Turbitt D, Smith G, Crook P, Severi E, Jones J, Ibbotson S, Marshall R, Smallwood CAH, Isla N, Memish ZA, Al-Rabeeah AA, Barbeschi M, Heymann DL, Zumla A.

Lancet. 2014 Jun 14;383(9934):2083-2089. doi: 10.1016/S0140-6736(13)62342-9. Epub 2014 May 20. Review.

PMID:
24857700
46.

Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study.

Hayward AC, Fragaszy EB, Bermingham A, Wang L, Copas A, Edmunds WJ, Ferguson N, Goonetilleke N, Harvey G, Kovar J, Lim MS, McMichael A, Millett ER, Nguyen-Van-Tam JS, Nazareth I, Pebody R, Tabassum F, Watson JM, Wurie FB, Johnson AM, Zambon M; Flu Watch Group.

Lancet Respir Med. 2014 Jun;2(6):445-54. doi: 10.1016/S2213-2600(14)70034-7. Epub 2014 Mar 17.

47.

A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant.

Agnihothram S, Yount BL Jr, Donaldson EF, Huynh J, Menachery VD, Gralinski LE, Graham RL, Becker MM, Tomar S, Scobey TD, Osswald HL, Whitmore A, Gopal R, Ghosh AK, Mesecar A, Zambon M, Heise M, Denison MR, Baric RS.

MBio. 2014 Mar 25;5(2):e00047-14. doi: 10.1128/mBio.00047-14.

48.

Open source clinical science for emerging infections.

Dunning JW, Merson L, Rohde GGU, Gao Z, Semple MG, Tran D, Gordon A, Olliaro PL, Khoo SH, Bruzzone R, Horby P, Cobb JP, Longuere KS, Kellam P, Nichol A, Brett S, Everett D, Walsh TS, Hien TT, Yu H, Zambon M, Ruiz-Palacios G, Lang T, Akhvlediani T; ISARIC Working Group 3, ISARIC Council, Hayden FG, Marshall J, Webb S, Angus DC, Shindo N, van der Werf S, Openshaw PJM, Farrar J, Carson G, Baillie JK.

Lancet Infect Dis. 2014 Jan;14(1):8-9. doi: 10.1016/S1473-3099(13)70327-X. No abstract available.

PMID:
24355025
49.

Mortality attributable to influenza in England and Wales prior to, during and after the 2009 pandemic.

Green HK, Andrews N, Fleming D, Zambon M, Pebody R.

PLoS One. 2013 Dec 11;8(12):e79360. doi: 10.1371/journal.pone.0079360. eCollection 2013.

50.

Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses.

Agnihothram S, Gopal R, Yount BL Jr, Donaldson EF, Menachery VD, Graham RL, Scobey TD, Gralinski LE, Denison MR, Zambon M, Baric RS.

J Infect Dis. 2014 Apr 1;209(7):995-1006. doi: 10.1093/infdis/jit609. Epub 2013 Nov 18.

Supplemental Content

Loading ...
Support Center